Abstract
Establishing the activity of a drug in a clinical condition implies that the disease or the diseases that the drug is supposed to treat are well defined and that a consensus exists on the clinical features that make the condition recognisable as a disease.
This is a preview of subscription content, log in via an institution to check access.
Preview
Unable to display preview. Download preview PDF.
References
Arfwidsson, L., D’Ella, G. and Laurell, B. (1974). Can self-rating replace doctors’ rating in evaluating anti-depressive treatment? Acta Psychiat. Scand., 50, 16–22
Ashton, C. M. (1984). Benzodiazepine withdrawal an unfinished story. Br. Med. J., 288, 1135–40
Barrett, J. E. and Di Mascio, A. (1966). Comparative effects on anxiety of the ‘minor tranquilizers’ in ‘high’ and ‘low’ anxious student volunteers. Dis. Nerv. Syst., 27, 483–6
Cattell, R. B. and Scheier, J. H. (1960). The Meaning and Measurement of Neuroticism and Anxiety. Ronald Press, New York
Cole, J. O., Hecht Orzack, M., Beake, B., Bird, M. and Bartal, Y. (1982). Assessment of the abuse liability of buspirone in recreational sedative users. J. Clin. Psychiatry, 43, 69–74
Derogatis, L. R., Ronald, S., Rickeis, K., Uhlenhuth, E. H. and Covi, L. (1974). In Pichot, P. and Olivier-Martin, R. Psychological Measurements in Psychopharmacology. Karger, London ECDEU Assessment Manual DHEW Publication No. (ADM), 1976
Eysenck, H. J. (1963). In Eysenck, H. J. (Ed.), Experiments with Drugs. Pergamon Press, Oxford, pp. 1–24
Feighner, J. P., Robins, E., Guze, S. B., Woodruff, R. A., Winokuz, G. and Munoz, R. (1972). Diagnostic criteria for use in psychiatric research. Arch. Gen. Psychiat., 26, 57–67
Finney, J. C. C. (1965). Psychol. Rep., 17, 707–13
Fontaine, R., Chouinard, G. and Annable, L. (1984). Am. J. Psychiat., 141, 848–52
Free, S. M. and Guthrie, M. B. (1969). J. Clin. Pharm., 9, 187–94
Fyer, A. J., Mannuzza, S. and Endicott, J. (1987). In Meitzer, H.Y. (Ed.), Psychopharmacology: The Third Generation of Progress. Raven Press, New York, pp. 1177–91
Goldberg, D. P. and Hillier, V. F. (1979). A scaled version of the General Health Questionnaire. Psychol. Med., 9, 139–45
Griffith, J. D., Jasinski, D. R., Casten, G. P. and McKinley, G. R. (1986). Investigation of the abuse liability of buspirone in alcohol dependent patients. Am J. Med., 80 (Suppl. 3B), 30–5
Hamilton, M. (1959). The assessment of anxiety states by rating. Br. J. Med. Psychol., 32, 50–5
Hamilton, M. (1987). In Hindmarch, I. and Stonier, P. D. (Eds.), Human Psychopharmacology, Measures and Methods, Vol. 1. John Wiley, Chichester, pp. 1–17
Hathaway, S. R. and McKinley, J. C. (1942). The Minnesota Multiphasic Personality Inventory. University of Minnesota Press, Minneapolis
Hindmarch, I. (1988). Critical Flicker Fusion Frequency (CFF): the effects of psychotropic compounds. Pharmacopsychiatria, 15, 44–8
Itil, T. M. and Huque, M. (1979). In Fielding, S. and Lal, H. (Eds.), Anxiolytics. Futura, New York, pp. 281–315
Janke, W., Debus, G. and Longo, N. (1979). In Boisser, J. R. (Ed.), Differential Psychopharmacology of Anxiolytics and Sedatives (Modern Problems of pharmacopsychiatry). Karger, Basle, pp. 13–98
Kahn, R. J., McNair, D. M., Lipman, R. S., Covi, L., Rickeis, K., Downing, R., Fisher, S. and Frankenthaler, L. M. (1986). Arch. Gen. Psychiat., 43, 79–85
Kellner, R. and Sheffield, B. F. (1973). A self-rating scale of distress. Psychol. Med., 3, 88–100
Klein, D. F. (1981). In Klein, D. F. and Rabkin, J. G. (Eds.), Anxiety: New Research and Changing Concepts. Raven Press, New York, pp. 235–263
Lader, M. and Frcka, G. (1987). Subjective effects during administration and on discontinuation of zopiclone and tumazepam in normal subjects. Pharmacopsychiatria, 20, 67–71
Lader, M. and Olajide, D. (1987). A comparison of buspirone and placebo in relieving benzodiazepine withdrawal symptoms. J. Clin. Psychopharm., 7, 11–15
Laties, V. G. (1959). Effects of meprobamate on fear and palmar sweating. J. Abnorm. Soc. Psychol., 59, 155–61
Lehman, H. E. (1969. In Cerletti and Bove (Eds.), The Present Status of Psychotropic Drugs. Excerpta Medica, Amsterdam, pp. 168–75
Lipman, R. S. (1982). Psychopharm. Bull., 18, 69–77
Lipman, R. S., Rickeis, K., Covi, L., Derogatis, L. R. and Uhlenhuth, E. H. (1969). Factors of symptom distress. Doctor ratings of anxious neurotic outpatients. Arch. Gen. Psychiat., 21, 328–38
McNair, D. M., Lorr, M. and Droppleman, L. F. (1971). Manual: Profile of Mood States. Educational and Industrial Testing Services, San Diego
Musch, B., Morselli, P. L. and Priore, P. (1988). Clinical studies with the new anxiolytic alpidem in anxious patients: an overview of the European experiences. Pharm. Biochem. Behav., 29, 803–6
Petursson, H. and Lader, M. H. (1981). Benzodiazepine dependence. Br. J. Addict., 76, 133–45
Pillard, R. C. and Fisher, S. (1967). Effects of chlordiazepoxide and secobarbital on film induced anxiety. Psychopharmacologia, 12, 18–23
Rickeis, K., Csanalosi, I., Chung, H., Case, W. G., Pereira-Ogan, J. A. and Downing, R. W. (1974). Am. J. Psychiat., 131, 25–30
Rickeis, K. and Howard, K. (1970). Psychopharmacologia., 17, 338–44
Rickeis, K. and Schweizer, E. E. (1987). In Meitzer, Y. (Ed.), Psychopharmacology: The Third Generation of Progress. Raven Press, New York, pp. 1193–203
Saletu, B. (1979). In Fielding, S. and Lal, H. (Eds.), Anxiolytics. Futura, New York, pp. 317–41
Saletu, B. (1987). In Hindmarch, I. and Stonier, P. D. (Eds.), Human Psychopharmacology, Measures and Methods, Vol. 1. John Wiley, Chichester, pp. 173–200
Sheerhan, D. V. (1982). New Engl. J. Med., 307, 156–8
Spielberger, C. D., Gorsuch, R. L. and Lushene, R. E. (1970). Manual for the State-Trait Anxiety Inventory. Consulting Psychologist Press, Palo Alto
Spitzer, R. L., Endicott, J. and Robins, E. (1978). Arch. Gen. Psychiat., 35, 773–82
Taylor, J. A. (1951). J. Exp. Psychol., 42, 183–8
Tyrer, P., Rutherford, D. and Huggett, T. (1981). Benzodiazepine withdrawal Symptoms and propanolol. Lancet, 1, 520–2
Uhr, L. and Miller, J. G. (1959). Experimentally determined effects of envylcamate on performance, autonomic response, and subjective reactions under stress. Ann. J. Med. Sci., 240, 204–11
Villeneuve, A. (1979). In Boisser, J. R. (Ed.), Differential Psychopharmacology of Anxiolytics and Sedative (Modern Problems of Pharmacopsychiatry). Karger, Basle, pp. 1–12
Vogel, J. R. (1979). In Fielding, S. and Lal, H. (Eds.), Anxiolytics. Futura, New York, pp. 343–73
Welsh, G. S. (1956). In Welsh, G. S. and Dahlstrom, W. G. (Eds.), Basic Readings on the MMPI in Psychology and Medicine. University of Minnesota Press, Minneapolis, pp. 264–81
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Copyright information
© 1990 The editors and contributors
About this chapter
Cite this chapter
Musch, B. (1990). Anxiolytics. In: O’Grady, J., Linet, O.I. (eds) Early Phase Drug Evaluation in Man. Palgrave, London. https://doi.org/10.1007/978-1-349-10705-6_32
Download citation
DOI: https://doi.org/10.1007/978-1-349-10705-6_32
Publisher Name: Palgrave, London
Print ISBN: 978-1-349-10707-0
Online ISBN: 978-1-349-10705-6
eBook Packages: EngineeringEngineering (R0)